Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-10-23

AUTHORS

Steve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, Melanie Valenti, Gary Box, Liam Jenkins, Caterina Mancusi, Annette Self, Floriana Manodoro, Ioannis Assiotis, Penny Robinson, Ritika Chauhan, Alistair G. Rust, Nik Matthews, Kate Eason, Khurum Khan, Naureen Starling, David Cunningham, Anguraj Sadanandam, Clare M. Isacke, Vladimir Kirkin, Nicola Valeri, Steven R. Whittaker

ABSTRACT

Despite showing clinical activity in BRAF-mutant melanoma, the MEK inhibitor (MEKi) trametinib has failed to show clinical benefit in KRAS-mutant colorectal cancer. To identify mechanisms of resistance to MEKi, we employed a pharmacogenomic analysis of MEKi-sensitive versus MEKi-resistant colorectal cancer cell lines. Strikingly, interferon- and inflammatory-related gene sets were enriched in cell lines exhibiting intrinsic and acquired resistance to MEK inhibition. The bromodomain inhibitor JQ1 suppressed interferon-stimulated gene (ISG) expression and in combination with MEK inhibitors displayed synergistic effects and induced apoptosis in MEKi-resistant colorectal cancer cell lines. ISG expression was confirmed in patient-derived organoid models, which displayed resistance to trametinib and were resensitized by JQ1 co-treatment. In in vivo models of colorectal cancer, combination treatment significantly suppressed tumor growth. Our findings provide a novel explanation for the limited response to MEK inhibitors in KRAS-mutant colorectal cancer, known for its inflammatory nature. Moreover, the high expression of ISGs was associated with significantly reduced survival of colorectal cancer patients. Excitingly, we have identified novel therapeutic opportunities to overcome intrinsic and acquired resistance to MEK inhibition in colorectal cancer. More... »

PAGES

1717-1733

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41388-018-0554-z

DOI

http://dx.doi.org/10.1038/s41388-018-0554-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1107791328

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30353166


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Azepines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colorectal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Synergism", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Regulation, Neoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Regulatory Networks", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interferons", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mutation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Organoids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins p21(ras)", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyridones", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrimidinones", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Triazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Xenograft Model Antitumor Assays", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wagner", 
        "givenName": "Steve", 
        "id": "sg:person.01340145077.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340145077.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Molecular Pathology, The Institute of Cancer Research, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Division of Molecular Pathology, The Institute of Cancer Research, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vlachogiannis", 
        "givenName": "Georgios", 
        "id": "sg:person.013063347127.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013063347127.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "De Haven Brandon", 
        "givenName": "Alexis", 
        "id": "sg:person.01365342406.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365342406.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Valenti", 
        "givenName": "Melanie", 
        "id": "sg:person.01016205147.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016205147.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Box", 
        "givenName": "Gary", 
        "id": "sg:person.01075035054.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075035054.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jenkins", 
        "givenName": "Liam", 
        "id": "sg:person.016012676630.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016012676630.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mancusi", 
        "givenName": "Caterina", 
        "id": "sg:person.014144523007.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014144523007.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Self", 
        "givenName": "Annette", 
        "id": "sg:person.01172433647.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172433647.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tumour Profiling Unit, The Institute of Cancer Research, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Tumour Profiling Unit, The Institute of Cancer Research, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Manodoro", 
        "givenName": "Floriana", 
        "id": "sg:person.0676075761.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676075761.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tumour Profiling Unit, The Institute of Cancer Research, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Tumour Profiling Unit, The Institute of Cancer Research, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Assiotis", 
        "givenName": "Ioannis", 
        "id": "sg:person.01216313563.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216313563.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tumour Profiling Unit, The Institute of Cancer Research, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Tumour Profiling Unit, The Institute of Cancer Research, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Robinson", 
        "givenName": "Penny", 
        "id": "sg:person.010305430524.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010305430524.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tumour Profiling Unit, The Institute of Cancer Research, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Tumour Profiling Unit, The Institute of Cancer Research, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chauhan", 
        "givenName": "Ritika", 
        "id": "sg:person.010523344614.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010523344614.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tumour Profiling Unit, The Institute of Cancer Research, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Tumour Profiling Unit, The Institute of Cancer Research, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rust", 
        "givenName": "Alistair G.", 
        "id": "sg:person.01301504422.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301504422.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tumour Profiling Unit, The Institute of Cancer Research, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Tumour Profiling Unit, The Institute of Cancer Research, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matthews", 
        "givenName": "Nik", 
        "id": "sg:person.01006330237.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006330237.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Molecular Pathology, The Institute of Cancer Research, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Division of Molecular Pathology, The Institute of Cancer Research, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eason", 
        "givenName": "Kate", 
        "id": "sg:person.016656372430.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016656372430.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Khan", 
        "givenName": "Khurum", 
        "id": "sg:person.01124306174.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124306174.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Starling", 
        "givenName": "Naureen", 
        "id": "sg:person.01136565472.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136565472.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cunningham", 
        "givenName": "David", 
        "id": "sg:person.01320161130.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320161130.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Molecular Pathology, The Institute of Cancer Research, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Division of Molecular Pathology, The Institute of Cancer Research, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sadanandam", 
        "givenName": "Anguraj", 
        "id": "sg:person.01052433537.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052433537.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Isacke", 
        "givenName": "Clare M.", 
        "id": "sg:person.013423075051.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013423075051.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kirkin", 
        "givenName": "Vladimir", 
        "id": "sg:person.01316763030.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316763030.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.5072.0", 
          "name": [
            "Division of Molecular Pathology, The Institute of Cancer Research, London, UK", 
            "Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Valeri", 
        "givenName": "Nicola", 
        "id": "sg:person.01015102731.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01015102731.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.18886.3f", 
          "name": [
            "Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Whittaker", 
        "givenName": "Steven R.", 
        "id": "sg:person.0630175743.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630175743.81"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/onc.2013.179", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046621808", 
          "https://doi.org/10.1038/onc.2013.179"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6605642", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034513961", 
          "https://doi.org/10.1038/sj.bjc.6605642"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm.3175", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031452671", 
          "https://doi.org/10.1038/nm.3175"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature09504", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001851540", 
          "https://doi.org/10.1038/nature09504"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature13561", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053323056", 
          "https://doi.org/10.1038/nature13561"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature09589", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049984554", 
          "https://doi.org/10.1038/nature09589"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrd4281", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012432963", 
          "https://doi.org/10.1038/nrd4281"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature11003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036060000", 
          "https://doi.org/10.1038/nature11003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2105-10-161", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024417609", 
          "https://doi.org/10.1186/1471-2105-10-161"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature18600", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044449046", 
          "https://doi.org/10.1038/nature18600"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature11252", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010619765", 
          "https://doi.org/10.1038/nature11252"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrclinonc.2015.105", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027934227", 
          "https://doi.org/10.1038/nrclinonc.2015.105"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-10-23", 
    "datePublishedReg": "2018-10-23", 
    "description": "Despite showing clinical activity in BRAF-mutant melanoma, the MEK inhibitor (MEKi) trametinib has failed to show clinical benefit in KRAS-mutant colorectal cancer. To identify mechanisms of resistance to MEKi, we employed a pharmacogenomic analysis of MEKi-sensitive versus MEKi-resistant colorectal cancer cell lines. Strikingly, interferon- and inflammatory-related gene sets were enriched in cell lines exhibiting intrinsic and acquired resistance to MEK inhibition. The bromodomain inhibitor JQ1 suppressed interferon-stimulated gene (ISG) expression and in combination with MEK inhibitors displayed synergistic effects and induced apoptosis in MEKi-resistant colorectal cancer cell lines. ISG expression was confirmed in patient-derived organoid models, which displayed resistance to trametinib and were resensitized by JQ1 co-treatment. In in vivo models of colorectal cancer, combination treatment significantly suppressed tumor growth. Our findings provide a novel explanation for the limited response to MEK inhibitors in KRAS-mutant colorectal cancer, known for its inflammatory nature. Moreover, the high expression of ISGs was associated with significantly reduced survival of colorectal cancer patients. Excitingly, we have identified novel therapeutic opportunities to overcome intrinsic and acquired resistance to MEK inhibition in colorectal cancer.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/s41388-018-0554-z", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.8483119", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3792899", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.5139597", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.4694155", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.7751366", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1097543", 
        "issn": [
          "0950-9232", 
          "1476-5594"
        ], 
        "name": "Oncogene", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "10", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "38"
      }
    ], 
    "keywords": [
      "KRAS-mutant colorectal cancer", 
      "colorectal cancer cell lines", 
      "colorectal cancer", 
      "MEK inhibition", 
      "cancer cell lines", 
      "MEK inhibitors", 
      "patient-derived organoid models", 
      "cell lines", 
      "colorectal cancer patients", 
      "MEK inhibitor trametinib", 
      "interferon-stimulated gene expression", 
      "BRAF-mutant melanoma", 
      "novel therapeutic opportunities", 
      "bromodomain inhibitor JQ1", 
      "inflammatory nature", 
      "clinical benefit", 
      "cancer patients", 
      "mechanisms of resistance", 
      "clinical activity", 
      "combination treatment", 
      "tumor growth", 
      "vivo model", 
      "ISG expression", 
      "therapeutic opportunities", 
      "pharmacogenomic analysis", 
      "cancer", 
      "inhibitor JQ1", 
      "interferon gene expression", 
      "gene expression", 
      "high expression", 
      "organoid models", 
      "limited response", 
      "trametinib", 
      "inhibition", 
      "JQ1", 
      "inhibitors", 
      "expression", 
      "patients", 
      "interferon", 
      "melanoma", 
      "MEKi", 
      "survival", 
      "resistance", 
      "treatment", 
      "apoptosis", 
      "gene sets", 
      "ISGs", 
      "synergistic effect", 
      "suppression", 
      "findings", 
      "lines", 
      "response", 
      "activity", 
      "benefits", 
      "effect", 
      "novel explanation", 
      "mechanism", 
      "combination", 
      "analysis", 
      "model", 
      "growth", 
      "opportunities", 
      "explanation", 
      "nature", 
      "set"
    ], 
    "name": "Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer", 
    "pagination": "1717-1733", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1107791328"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41388-018-0554-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30353166"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41388-018-0554-z", 
      "https://app.dimensions.ai/details/publication/pub.1107791328"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:44", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_776.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/s41388-018-0554-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41388-018-0554-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41388-018-0554-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41388-018-0554-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41388-018-0554-z'


 

This table displays all metadata directly associated to this object as RDF triples.

424 TRIPLES      21 PREDICATES      121 URIs      101 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41388-018-0554-z schema:about N0b1fb3f909ed497aadf629cf1ed795aa
2 N1a3fec32701b4699a0fd77dbe479b0a3
3 N36d470a02b4e48f1a8a881b3954ecf19
4 N381f1da9aa0f42efafe22870ca697e27
5 N4293595581714bd49e2737207cdc0e43
6 N5395c162c0a64f0ea38e5f8c96c78837
7 N61e81ce91bfd4fc8b243861252165ae4
8 N7645b09876f047779355df3f122b5e23
9 N7999cebe456a4222b3914f8a4353222a
10 N7a6251924f694853904d9e0502877edd
11 N816438d26e02482090d3055e8ed32b3e
12 N96a99fe151f34e0a9077f16d4c8f20d9
13 Na184da5f43bc4a988ea7b5c1f8263005
14 Nb3c7428fbbd14391b018933dd263d81d
15 Nb596383a5c614e10a735d799f9b7b6d3
16 Nd1a9b84c5480487a9e629c90401bc568
17 Nd329fbc40c6a4c1f89bf1c020a6de2fd
18 Nd92bd9810d2e44d98c34dc97cebb996a
19 Nf52c9dc419bf4446bbcadbd1446899c6
20 anzsrc-for:11
21 anzsrc-for:1112
22 schema:author N6259ce6fef8849418dd6305b0cdbed81
23 schema:citation sg:pub.10.1038/nature09504
24 sg:pub.10.1038/nature09589
25 sg:pub.10.1038/nature11003
26 sg:pub.10.1038/nature11252
27 sg:pub.10.1038/nature13561
28 sg:pub.10.1038/nature18600
29 sg:pub.10.1038/nm.3175
30 sg:pub.10.1038/nrclinonc.2015.105
31 sg:pub.10.1038/nrd4281
32 sg:pub.10.1038/onc.2013.179
33 sg:pub.10.1038/sj.bjc.6605642
34 sg:pub.10.1186/1471-2105-10-161
35 schema:datePublished 2018-10-23
36 schema:datePublishedReg 2018-10-23
37 schema:description Despite showing clinical activity in BRAF-mutant melanoma, the MEK inhibitor (MEKi) trametinib has failed to show clinical benefit in KRAS-mutant colorectal cancer. To identify mechanisms of resistance to MEKi, we employed a pharmacogenomic analysis of MEKi-sensitive versus MEKi-resistant colorectal cancer cell lines. Strikingly, interferon- and inflammatory-related gene sets were enriched in cell lines exhibiting intrinsic and acquired resistance to MEK inhibition. The bromodomain inhibitor JQ1 suppressed interferon-stimulated gene (ISG) expression and in combination with MEK inhibitors displayed synergistic effects and induced apoptosis in MEKi-resistant colorectal cancer cell lines. ISG expression was confirmed in patient-derived organoid models, which displayed resistance to trametinib and were resensitized by JQ1 co-treatment. In in vivo models of colorectal cancer, combination treatment significantly suppressed tumor growth. Our findings provide a novel explanation for the limited response to MEK inhibitors in KRAS-mutant colorectal cancer, known for its inflammatory nature. Moreover, the high expression of ISGs was associated with significantly reduced survival of colorectal cancer patients. Excitingly, we have identified novel therapeutic opportunities to overcome intrinsic and acquired resistance to MEK inhibition in colorectal cancer.
38 schema:genre article
39 schema:isAccessibleForFree true
40 schema:isPartOf N6703b064a20540b8a585d98188b1c1cf
41 Ndda64e3409cb4ea8924298467dc97ee6
42 sg:journal.1097543
43 schema:keywords BRAF-mutant melanoma
44 ISG expression
45 ISGs
46 JQ1
47 KRAS-mutant colorectal cancer
48 MEK inhibition
49 MEK inhibitor trametinib
50 MEK inhibitors
51 MEKi
52 activity
53 analysis
54 apoptosis
55 benefits
56 bromodomain inhibitor JQ1
57 cancer
58 cancer cell lines
59 cancer patients
60 cell lines
61 clinical activity
62 clinical benefit
63 colorectal cancer
64 colorectal cancer cell lines
65 colorectal cancer patients
66 combination
67 combination treatment
68 effect
69 explanation
70 expression
71 findings
72 gene expression
73 gene sets
74 growth
75 high expression
76 inflammatory nature
77 inhibition
78 inhibitor JQ1
79 inhibitors
80 interferon
81 interferon gene expression
82 interferon-stimulated gene expression
83 limited response
84 lines
85 mechanism
86 mechanisms of resistance
87 melanoma
88 model
89 nature
90 novel explanation
91 novel therapeutic opportunities
92 opportunities
93 organoid models
94 patient-derived organoid models
95 patients
96 pharmacogenomic analysis
97 resistance
98 response
99 set
100 suppression
101 survival
102 synergistic effect
103 therapeutic opportunities
104 trametinib
105 treatment
106 tumor growth
107 vivo model
108 schema:name Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
109 schema:pagination 1717-1733
110 schema:productId N084483d3f13a42ecbb25c57cfb2f67c3
111 N6814d269822b4fec9cff6a5591264f59
112 Nda96fbbf81274c6aa26274442dcd716c
113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107791328
114 https://doi.org/10.1038/s41388-018-0554-z
115 schema:sdDatePublished 2022-10-01T06:44
116 schema:sdLicense https://scigraph.springernature.com/explorer/license/
117 schema:sdPublisher Ncbb78bb373734d8a9b68041a14815076
118 schema:url https://doi.org/10.1038/s41388-018-0554-z
119 sgo:license sg:explorer/license/
120 sgo:sdDataset articles
121 rdf:type schema:ScholarlyArticle
122 N084483d3f13a42ecbb25c57cfb2f67c3 schema:name dimensions_id
123 schema:value pub.1107791328
124 rdf:type schema:PropertyValue
125 N0b1fb3f909ed497aadf629cf1ed795aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Organoids
127 rdf:type schema:DefinedTerm
128 N18f57c7b28324e5fad85c82b98fbc5ff rdf:first sg:person.014144523007.05
129 rdf:rest Nb10bc8955e584f378844ae0e6228c104
130 N1a3fec32701b4699a0fd77dbe479b0a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Animals
132 rdf:type schema:DefinedTerm
133 N28a9b6740f014ded8228164666e0902b rdf:first sg:person.01015102731.05
134 rdf:rest N297e23bef5ab4b629f81e7377cf99926
135 N297e23bef5ab4b629f81e7377cf99926 rdf:first sg:person.0630175743.81
136 rdf:rest rdf:nil
137 N36d470a02b4e48f1a8a881b3954ecf19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Interferons
139 rdf:type schema:DefinedTerm
140 N381f1da9aa0f42efafe22870ca697e27 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Mutation
142 rdf:type schema:DefinedTerm
143 N401e4cd623c44d8d9ed9ed73241b25d0 rdf:first sg:person.01016205147.72
144 rdf:rest Ndface9973369448b828e5484e20b4106
145 N4293595581714bd49e2737207cdc0e43 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Mice
147 rdf:type schema:DefinedTerm
148 N5395c162c0a64f0ea38e5f8c96c78837 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Female
150 rdf:type schema:DefinedTerm
151 N61e81ce91bfd4fc8b243861252165ae4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Drug Resistance, Neoplasm
153 rdf:type schema:DefinedTerm
154 N6259ce6fef8849418dd6305b0cdbed81 rdf:first sg:person.01340145077.11
155 rdf:rest Ncc7f96184858466597c63a8b644c569f
156 N6703b064a20540b8a585d98188b1c1cf schema:issueNumber 10
157 rdf:type schema:PublicationIssue
158 N6814d269822b4fec9cff6a5591264f59 schema:name doi
159 schema:value 10.1038/s41388-018-0554-z
160 rdf:type schema:PropertyValue
161 N7645b09876f047779355df3f122b5e23 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Azepines
163 rdf:type schema:DefinedTerm
164 N7999cebe456a4222b3914f8a4353222a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Xenograft Model Antitumor Assays
166 rdf:type schema:DefinedTerm
167 N7a6251924f694853904d9e0502877edd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Triazoles
169 rdf:type schema:DefinedTerm
170 N807cc80a5fef405d93664a679e7f3b1c rdf:first sg:person.01124306174.74
171 rdf:rest Nf2ad02449d4f45a4b7b4adac8cea83c9
172 N816438d26e02482090d3055e8ed32b3e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Drug Synergism
174 rdf:type schema:DefinedTerm
175 N8a7f156491fe4805927620027f4a4e5e rdf:first sg:person.010305430524.45
176 rdf:rest Ncf32a12e5b9c425e9fdc1df4fe6fa7e6
177 N96a99fe151f34e0a9077f16d4c8f20d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Cell Line, Tumor
179 rdf:type schema:DefinedTerm
180 Na184da5f43bc4a988ea7b5c1f8263005 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Gene Expression Regulation, Neoplastic
182 rdf:type schema:DefinedTerm
183 Na27c0d1afeb34b3e876e4c9660fd6b7e rdf:first sg:person.01320161130.16
184 rdf:rest Nf5395a98f82f472892dfe8f6e9de7348
185 Na94f2e7f373b450b9ca4cfa19e27270f rdf:first sg:person.01316763030.17
186 rdf:rest N28a9b6740f014ded8228164666e0902b
187 Nac357caa816d44e9a6aa4b0a05344bb1 rdf:first sg:person.01365342406.76
188 rdf:rest N401e4cd623c44d8d9ed9ed73241b25d0
189 Nad442dd9662d442b979387c91cc6baa9 rdf:first sg:person.01216313563.17
190 rdf:rest N8a7f156491fe4805927620027f4a4e5e
191 Nadc21aed26d64266a72fc7b5da613330 rdf:first sg:person.016656372430.18
192 rdf:rest N807cc80a5fef405d93664a679e7f3b1c
193 Nb10bc8955e584f378844ae0e6228c104 rdf:first sg:person.01172433647.05
194 rdf:rest Ne07e4c849d9948e4b26eb18e190408e5
195 Nb3c7428fbbd14391b018933dd263d81d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Colorectal Neoplasms
197 rdf:type schema:DefinedTerm
198 Nb596383a5c614e10a735d799f9b7b6d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Pyridones
200 rdf:type schema:DefinedTerm
201 Ncbb78bb373734d8a9b68041a14815076 schema:name Springer Nature - SN SciGraph project
202 rdf:type schema:Organization
203 Ncc7f96184858466597c63a8b644c569f rdf:first sg:person.013063347127.97
204 rdf:rest Nac357caa816d44e9a6aa4b0a05344bb1
205 Ncf32a12e5b9c425e9fdc1df4fe6fa7e6 rdf:first sg:person.010523344614.01
206 rdf:rest Ne6e6d3c6fb9e4a45a9886be2701e0625
207 Nd1a9b84c5480487a9e629c90401bc568 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
208 schema:name Humans
209 rdf:type schema:DefinedTerm
210 Nd329fbc40c6a4c1f89bf1c020a6de2fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Pyrimidinones
212 rdf:type schema:DefinedTerm
213 Nd92bd9810d2e44d98c34dc97cebb996a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
214 schema:name Gene Regulatory Networks
215 rdf:type schema:DefinedTerm
216 Nda96fbbf81274c6aa26274442dcd716c schema:name pubmed_id
217 schema:value 30353166
218 rdf:type schema:PropertyValue
219 Ndda64e3409cb4ea8924298467dc97ee6 schema:volumeNumber 38
220 rdf:type schema:PublicationVolume
221 Nde3bd1b1c60a4780a52a04c908277f5b rdf:first sg:person.013423075051.94
222 rdf:rest Na94f2e7f373b450b9ca4cfa19e27270f
223 Ndface9973369448b828e5484e20b4106 rdf:first sg:person.01075035054.24
224 rdf:rest Ne06a97e9f805476ab3fa313190abc3b6
225 Ne06a97e9f805476ab3fa313190abc3b6 rdf:first sg:person.016012676630.99
226 rdf:rest N18f57c7b28324e5fad85c82b98fbc5ff
227 Ne07e4c849d9948e4b26eb18e190408e5 rdf:first sg:person.0676075761.67
228 rdf:rest Nad442dd9662d442b979387c91cc6baa9
229 Ne6e6d3c6fb9e4a45a9886be2701e0625 rdf:first sg:person.01301504422.86
230 rdf:rest Nfed54cbb837f42bbaefca8edd84d56a4
231 Nf2ad02449d4f45a4b7b4adac8cea83c9 rdf:first sg:person.01136565472.17
232 rdf:rest Na27c0d1afeb34b3e876e4c9660fd6b7e
233 Nf52c9dc419bf4446bbcadbd1446899c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
234 schema:name Proto-Oncogene Proteins p21(ras)
235 rdf:type schema:DefinedTerm
236 Nf5395a98f82f472892dfe8f6e9de7348 rdf:first sg:person.01052433537.19
237 rdf:rest Nde3bd1b1c60a4780a52a04c908277f5b
238 Nfed54cbb837f42bbaefca8edd84d56a4 rdf:first sg:person.01006330237.21
239 rdf:rest Nadc21aed26d64266a72fc7b5da613330
240 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
241 schema:name Medical and Health Sciences
242 rdf:type schema:DefinedTerm
243 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
244 schema:name Oncology and Carcinogenesis
245 rdf:type schema:DefinedTerm
246 sg:grant.3792899 http://pending.schema.org/fundedItem sg:pub.10.1038/s41388-018-0554-z
247 rdf:type schema:MonetaryGrant
248 sg:grant.4694155 http://pending.schema.org/fundedItem sg:pub.10.1038/s41388-018-0554-z
249 rdf:type schema:MonetaryGrant
250 sg:grant.5139597 http://pending.schema.org/fundedItem sg:pub.10.1038/s41388-018-0554-z
251 rdf:type schema:MonetaryGrant
252 sg:grant.7751366 http://pending.schema.org/fundedItem sg:pub.10.1038/s41388-018-0554-z
253 rdf:type schema:MonetaryGrant
254 sg:grant.8483119 http://pending.schema.org/fundedItem sg:pub.10.1038/s41388-018-0554-z
255 rdf:type schema:MonetaryGrant
256 sg:journal.1097543 schema:issn 0950-9232
257 1476-5594
258 schema:name Oncogene
259 schema:publisher Springer Nature
260 rdf:type schema:Periodical
261 sg:person.01006330237.21 schema:affiliation grid-institutes:grid.18886.3f
262 schema:familyName Matthews
263 schema:givenName Nik
264 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006330237.21
265 rdf:type schema:Person
266 sg:person.01015102731.05 schema:affiliation grid-institutes:grid.5072.0
267 schema:familyName Valeri
268 schema:givenName Nicola
269 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01015102731.05
270 rdf:type schema:Person
271 sg:person.01016205147.72 schema:affiliation grid-institutes:grid.18886.3f
272 schema:familyName Valenti
273 schema:givenName Melanie
274 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01016205147.72
275 rdf:type schema:Person
276 sg:person.010305430524.45 schema:affiliation grid-institutes:grid.18886.3f
277 schema:familyName Robinson
278 schema:givenName Penny
279 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010305430524.45
280 rdf:type schema:Person
281 sg:person.010523344614.01 schema:affiliation grid-institutes:grid.18886.3f
282 schema:familyName Chauhan
283 schema:givenName Ritika
284 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010523344614.01
285 rdf:type schema:Person
286 sg:person.01052433537.19 schema:affiliation grid-institutes:grid.18886.3f
287 schema:familyName Sadanandam
288 schema:givenName Anguraj
289 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052433537.19
290 rdf:type schema:Person
291 sg:person.01075035054.24 schema:affiliation grid-institutes:grid.18886.3f
292 schema:familyName Box
293 schema:givenName Gary
294 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075035054.24
295 rdf:type schema:Person
296 sg:person.01124306174.74 schema:affiliation grid-institutes:grid.5072.0
297 schema:familyName Khan
298 schema:givenName Khurum
299 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124306174.74
300 rdf:type schema:Person
301 sg:person.01136565472.17 schema:affiliation grid-institutes:grid.5072.0
302 schema:familyName Starling
303 schema:givenName Naureen
304 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136565472.17
305 rdf:type schema:Person
306 sg:person.01172433647.05 schema:affiliation grid-institutes:grid.18886.3f
307 schema:familyName Self
308 schema:givenName Annette
309 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172433647.05
310 rdf:type schema:Person
311 sg:person.01216313563.17 schema:affiliation grid-institutes:grid.18886.3f
312 schema:familyName Assiotis
313 schema:givenName Ioannis
314 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216313563.17
315 rdf:type schema:Person
316 sg:person.01301504422.86 schema:affiliation grid-institutes:grid.18886.3f
317 schema:familyName Rust
318 schema:givenName Alistair G.
319 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301504422.86
320 rdf:type schema:Person
321 sg:person.013063347127.97 schema:affiliation grid-institutes:grid.18886.3f
322 schema:familyName Vlachogiannis
323 schema:givenName Georgios
324 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013063347127.97
325 rdf:type schema:Person
326 sg:person.01316763030.17 schema:affiliation grid-institutes:grid.18886.3f
327 schema:familyName Kirkin
328 schema:givenName Vladimir
329 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316763030.17
330 rdf:type schema:Person
331 sg:person.01320161130.16 schema:affiliation grid-institutes:grid.5072.0
332 schema:familyName Cunningham
333 schema:givenName David
334 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01320161130.16
335 rdf:type schema:Person
336 sg:person.01340145077.11 schema:affiliation grid-institutes:grid.18886.3f
337 schema:familyName Wagner
338 schema:givenName Steve
339 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340145077.11
340 rdf:type schema:Person
341 sg:person.013423075051.94 schema:affiliation grid-institutes:grid.18886.3f
342 schema:familyName Isacke
343 schema:givenName Clare M.
344 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013423075051.94
345 rdf:type schema:Person
346 sg:person.01365342406.76 schema:affiliation grid-institutes:grid.18886.3f
347 schema:familyName De Haven Brandon
348 schema:givenName Alexis
349 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365342406.76
350 rdf:type schema:Person
351 sg:person.014144523007.05 schema:affiliation grid-institutes:grid.18886.3f
352 schema:familyName Mancusi
353 schema:givenName Caterina
354 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014144523007.05
355 rdf:type schema:Person
356 sg:person.016012676630.99 schema:affiliation grid-institutes:grid.18886.3f
357 schema:familyName Jenkins
358 schema:givenName Liam
359 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016012676630.99
360 rdf:type schema:Person
361 sg:person.016656372430.18 schema:affiliation grid-institutes:grid.18886.3f
362 schema:familyName Eason
363 schema:givenName Kate
364 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016656372430.18
365 rdf:type schema:Person
366 sg:person.0630175743.81 schema:affiliation grid-institutes:grid.18886.3f
367 schema:familyName Whittaker
368 schema:givenName Steven R.
369 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630175743.81
370 rdf:type schema:Person
371 sg:person.0676075761.67 schema:affiliation grid-institutes:grid.18886.3f
372 schema:familyName Manodoro
373 schema:givenName Floriana
374 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676075761.67
375 rdf:type schema:Person
376 sg:pub.10.1038/nature09504 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001851540
377 https://doi.org/10.1038/nature09504
378 rdf:type schema:CreativeWork
379 sg:pub.10.1038/nature09589 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049984554
380 https://doi.org/10.1038/nature09589
381 rdf:type schema:CreativeWork
382 sg:pub.10.1038/nature11003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036060000
383 https://doi.org/10.1038/nature11003
384 rdf:type schema:CreativeWork
385 sg:pub.10.1038/nature11252 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010619765
386 https://doi.org/10.1038/nature11252
387 rdf:type schema:CreativeWork
388 sg:pub.10.1038/nature13561 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053323056
389 https://doi.org/10.1038/nature13561
390 rdf:type schema:CreativeWork
391 sg:pub.10.1038/nature18600 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044449046
392 https://doi.org/10.1038/nature18600
393 rdf:type schema:CreativeWork
394 sg:pub.10.1038/nm.3175 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031452671
395 https://doi.org/10.1038/nm.3175
396 rdf:type schema:CreativeWork
397 sg:pub.10.1038/nrclinonc.2015.105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027934227
398 https://doi.org/10.1038/nrclinonc.2015.105
399 rdf:type schema:CreativeWork
400 sg:pub.10.1038/nrd4281 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012432963
401 https://doi.org/10.1038/nrd4281
402 rdf:type schema:CreativeWork
403 sg:pub.10.1038/onc.2013.179 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046621808
404 https://doi.org/10.1038/onc.2013.179
405 rdf:type schema:CreativeWork
406 sg:pub.10.1038/sj.bjc.6605642 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034513961
407 https://doi.org/10.1038/sj.bjc.6605642
408 rdf:type schema:CreativeWork
409 sg:pub.10.1186/1471-2105-10-161 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024417609
410 https://doi.org/10.1186/1471-2105-10-161
411 rdf:type schema:CreativeWork
412 grid-institutes:grid.18886.3f schema:alternateName Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK
413 Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK
414 Division of Molecular Pathology, The Institute of Cancer Research, London, UK
415 Tumour Profiling Unit, The Institute of Cancer Research, London, UK
416 schema:name Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK
417 Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK
418 Division of Molecular Pathology, The Institute of Cancer Research, London, UK
419 Tumour Profiling Unit, The Institute of Cancer Research, London, UK
420 rdf:type schema:Organization
421 grid-institutes:grid.5072.0 schema:alternateName Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK
422 schema:name Department of Medicine, Royal Marsden NHS Foundation Trust, London, UK
423 Division of Molecular Pathology, The Institute of Cancer Research, London, UK
424 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...